Primary |
Prophylaxis |
23.1% |
Surgery |
10.3% |
Drug Use For Unknown Indication |
7.7% |
Mitral Valve Repair |
7.7% |
Antibiotic Prophylaxis |
5.1% |
Cellulitis |
5.1% |
Infection |
5.1% |
Osteomyelitis |
5.1% |
Product Used For Unknown Indication |
5.1% |
Blood Pressure Increased |
2.6% |
Infection Prophylaxis |
2.6% |
Inguinal Hernia Repair |
2.6% |
Knee Arthroplasty |
2.6% |
Post Procedural Complication |
2.6% |
Postoperative Care |
2.6% |
Preoperative Care |
2.6% |
Procedural Pain |
2.6% |
Sedation |
2.6% |
Urinary Tract Infection |
2.6% |
|
Rash |
14.7% |
Pancytopenia |
8.8% |
Urticaria |
8.8% |
Ventricular Septal Defect |
8.8% |
Anaphylactic Reaction |
5.9% |
Tremor |
5.9% |
Vomiting |
5.9% |
Wheezing |
5.9% |
Alanine Aminotransferase Increased |
2.9% |
Anaphylactic Shock |
2.9% |
Clostridial Infection |
2.9% |
Dizziness |
2.9% |
Drug Hypersensitivity |
2.9% |
Haemolytic Anaemia |
2.9% |
Hepatitis Acute |
2.9% |
Hyperglycaemia |
2.9% |
Laryngeal Oedema |
2.9% |
Liver Disorder |
2.9% |
Medication Error |
2.9% |
Nausea |
2.9% |
|
Secondary |
Drug Use For Unknown Indication |
60.7% |
Product Used For Unknown Indication |
19.2% |
Depression |
4.5% |
Prophylaxis |
2.7% |
Febrile Neutropenia |
2.2% |
Prophylaxis Of Nausea And Vomiting |
2.2% |
Pneumonia |
1.1% |
Hysterectomy |
0.9% |
Myelodysplastic Syndrome |
0.9% |
Anticoagulant Therapy |
0.7% |
Groin Abscess |
0.7% |
Serratia Sepsis |
0.7% |
Arthroscopy |
0.4% |
Bacteraemia |
0.4% |
Blood Cholesterol |
0.4% |
Intravenous Catheter Management |
0.4% |
Multiple Myeloma |
0.4% |
Plasma Cell Myeloma |
0.4% |
Postoperative Care |
0.4% |
Premedication |
0.4% |
|
Hepatitis |
10.0% |
Hyponatraemia |
10.0% |
Postoperative Infection |
10.0% |
Drug Hypersensitivity |
7.5% |
Pneumonia |
7.5% |
Urticaria |
7.5% |
Neuropathy Peripheral |
5.0% |
Post Procedural Infection |
5.0% |
Rash |
5.0% |
Swollen Tongue |
5.0% |
Vomiting |
5.0% |
Anaemia |
2.5% |
Clostridium Difficile Colitis |
2.5% |
Dermatitis Bullous |
2.5% |
Disability |
2.5% |
Drug-induced Liver Injury |
2.5% |
Febrile Neutropenia |
2.5% |
Groin Abscess |
2.5% |
Hepatotoxicity |
2.5% |
Infusion Site Erythema |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
53.1% |
Drug Use For Unknown Indication |
12.9% |
Coronary Artery Bypass |
8.8% |
Pain |
4.4% |
Aortic Valve Replacement |
2.5% |
Hypertension |
2.4% |
Musculoskeletal Pain |
2.2% |
Catheterisation Cardiac |
2.0% |
Mitral Valve Replacement |
1.3% |
Prophylaxis |
1.1% |
Metastases To Bone |
1.1% |
Mitral Valve Repair |
1.1% |
Bacterial Infection |
1.0% |
Foetal Exposure During Pregnancy |
1.0% |
Angiogram |
0.9% |
Depression |
0.9% |
Premedication |
0.9% |
Urinary Tract Infection |
0.8% |
Anxiety |
0.8% |
Breast Cancer |
0.8% |
|
Injury |
12.5% |
Pain |
10.2% |
Unevaluable Event |
9.6% |
Fear |
8.3% |
Anhedonia |
7.4% |
Anxiety |
6.3% |
Vomiting |
5.7% |
Emotional Distress |
4.8% |
Renal Failure |
4.8% |
Stress |
4.3% |
Depression |
4.0% |
Renal Injury |
3.4% |
Renal Failure Acute |
3.2% |
Weight Decreased |
2.9% |
Musculoskeletal Pain |
2.5% |
Renal Impairment |
2.5% |
Pneumonia |
2.2% |
Pulmonary Embolism |
2.2% |
Multi-organ Failure |
1.9% |
Deep Vein Thrombosis |
1.5% |
|
Interacting |
Convulsion |
50.0% |
Surgery |
50.0% |
|
|